Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04966026
NCT04966026CompletedNot Applicable

Study on the Clinical Characteristics and Outcome of Patients With COPD Combined With Pneumonia

Peking University Third Hospital1 site in 1 country143 target enrollmentStarted: March 1, 2017Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
143
Locations
1
Primary Endpoint
mortality rate
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.

Detailed Description

To identify the clinical characteristics of patients with chronic obstructive pulmonary disease (COPD) combined with community-acquired pneumonia (CAP) and the factors influencing clinical transition.Compared to other chronic airway diseases, COPD patients can often have CAP in combination, but there is a lack of comparative studies between COPD patients with CAP and non-COPD patients with CAP.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •CAP meets the diagnostic criteria published in 2016 Chinese CAP diagnosis and treatment guidelines; CPOPD and AECOPD meet the diagnostic criteria published in Chinese 2013 COPD diagnosis and treatment guidelines;
  • •Age ≧ 40years.

Exclusion Criteria

  • •age <40years;
  • •positive for human immunodeficiency virus (HIV) antibodies;
  • •suspected or confirmed tuberculosis or fungal infection of the lung.

Outcomes

Primary Outcomes

mortality rate

Time Frame: Day 28 from hospitalization

mortality rate

Secondary Outcomes

  • number of days in ICU(through study completion, an average of 1 year)
  • hospital fees(through study completion, an average of 1 year)
  • cause of using antimicrobial drugs(through study completion, an average of 1 year)
  • Number of days in hospital(through study completion, an average of 1 year)
  • number of days on mechanical ventilation(through study completion, an average of 1 year)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Patient Characteristics and Treatment Modalities in COPD Patients in ChinaPulmonary Disease, Chronic Obstructive
NCT03161587GlaxoSmithKline848
Recruiting
Not Applicable
Clinical Outcomes in Patients Referred to Pulmonary RehabilitationChronic Obstructive Pulmonary Disease
NCT03591263National Taiwan University Hospital1,000
Unknown
Not Applicable
The Clinical Application and Popularization of Portable Home Noninvasive VentilatorPulmonary Disease, Chronic ObstructiveHypercapnic Respiratory Failure
NCT03238339Mingdong Hu40
Completed
Not Applicable
Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and TaiwanPatients With Asthma-COPD Overlap Syndrome (ACOS)
NCT02878252AstraZeneca350
Completed
Phase 1
COPD Treatment by Transplantation of Autologous Bronchial Basal CellsChronic Obstructive Pulmonary Disease (COPD)
NCT05594303Guangzhou Institute of Respiratory Disease6